Correlation of platelet recovery after complete remission of induction chemotherapy with minimal residual disease and clinical characteristics in acute myeloid leukemia
10.3760/cma.j.cn115356-20220106-00007
- VernacularTitle:急性髓系白血病患者诱导化疗完全缓解后血小板计数恢复情况与微小残留病及临床特征的关系
- Author:
Haoyue CHEN
1
;
Miao SUN
;
Chunhua LIU
;
Qiaoyan HAN
;
Xiaorui LI
Author Information
1. 靖江市人民医院血液科，靖江 214500
- Keywords:
Leukemia, myeloid, acute;
Platelet count;
Minimal residual disease
- From:
Journal of Leukemia & Lymphoma
2022;31(11):655-658
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the correlation of excessive platelet (Plt) recovery at the first time of achieving morphologic complete remission (CR) after induction chemotherapy with minimal residual disease (MRD) and the clinical features of acute myeloid leukemia (AML).Methods:The clinical data of newly-treated 57 AML patients (except for acute promyelocytic leukemia) who achieved CR after induction chemotherapy in Jinjiang People's Hospital from January 2016 to December 2021 were retrospectively analyzed. A total of 57 newly diagnosed adult AML patients were divided into excessive Plt recovery group (Plt recovery>350×10 9/L) and normal Plt recovery group [Plt recovery: (100-350)×10 9/L] according to the Plt recovery. Meanwhile, the MRD was analyzed by using multiparameter flow cytometry (MFC) in patients achieving CR after receiving 1 course of standard treatment regimen or 1-2 courses of demethylation drugs combined with pre-conditioning regimen. The clinical features and negative rate of MRD between the two groups were compared. Results:Among 57 CR patients, 31 (54.4%) patients had CR with excessive Plt recovery and MFC-MRD negative rate was 67.7% (21/31); 26 (45.6%) had CR with normal Plt recovery and MFC-MRD negative rate was 38.5% (10/26); and the difference in the proportion of MRD negative patients between the both groups was statistically significant ( χ2 = 4.89, P = 0.027). There were no statistically differences in the proportions of patients with different gender, age, WBC at initial diagnosis, Plt, chemotherapy regimen and risk degree classification between the two groups (all P > 0.05). Conclusions:In AML patients, excessive Plt recovery at the first time of achieving morphologic CR after induction chemotherapy is associated with negative MRD, which has a certain value in the judgement of therapeutic effect.
